247 related articles for article (PubMed ID: 31371177)
1. Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer.
Wang T; Subramanian C; Yu M; White PT; Kuai R; Sanchez J; Moon JJ; Timmermann BN; Schwendeman A; Cohen MS
Surgery; 2019 Dec; 166(6):1168-1175. PubMed ID: 31371177
[TBL] [Abstract][Full Text] [Related]
2. Synthetic high-density lipoprotein nanodisks for targeted withalongolide delivery to adrenocortical carcinoma.
Kuai R; Subramanian C; White PT; Timmermann BN; Moon JJ; Cohen MS; Schwendeman A
Int J Nanomedicine; 2017; 12():6581-6594. PubMed ID: 28919755
[TBL] [Abstract][Full Text] [Related]
3. Synthetic high-density lipoprotein nanoconjugate targets neuroblastoma stem cells, blocking migration and self-renewal.
Subramanian C; White PT; Kuai R; Kalidindi A; Castle VP; Moon JJ; Timmermann BN; Schwendeman A; Cohen MS
Surgery; 2018 May; ():. PubMed ID: 29753460
[TBL] [Abstract][Full Text] [Related]
4. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
[TBL] [Abstract][Full Text] [Related]
5. Synthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomas.
Subramanian C; Kuai R; Zhu Q; White P; Moon JJ; Schwendeman A; Cohen MS
Surgery; 2016 Jan; 159(1):284-94. PubMed ID: 26582501
[TBL] [Abstract][Full Text] [Related]
6. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
8. Milk derived colloid as a novel drug delivery carrier for breast cancer.
Hayashi M; Silanikove N; Chang X; Ravi R; Pham V; Baia G; Paz K; Brait M; Koch WM; Sidransky D
Cancer Biol Ther; 2015; 16(8):1184-93. PubMed ID: 26046946
[TBL] [Abstract][Full Text] [Related]
9. Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery.
Sabnis S; Sabnis NA; Raut S; Lacko AG
Int J Nanomedicine; 2017; 12():1453-1464. PubMed ID: 28260891
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia-mediated drug delivery induces biological effects at the tumor and molecular levels that improve cisplatin efficacy in triple negative breast cancer.
Dunne M; Dou YN; Drake DM; Spence T; Gontijo SML; Wells PG; Allen C
J Control Release; 2018 Jul; 282():35-45. PubMed ID: 29673642
[TBL] [Abstract][Full Text] [Related]
11. Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.
Mooberry LK; Nair M; Paranjape S; McConathy WJ; Lacko AG
J Drug Target; 2010 Jan; 18(1):53-8. PubMed ID: 19637935
[TBL] [Abstract][Full Text] [Related]
12. Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice.
Traughber CA; Opoku E; Brubaker G; Major J; Lu H; Lorkowski SW; Neumann C; Hardaway A; Chung YM; Gulshan K; Sharifi N; Brown JM; Smith JD
J Biol Chem; 2020 Jun; 295(24):8252-8261. PubMed ID: 32358065
[TBL] [Abstract][Full Text] [Related]
13. Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer.
Yuan H; Guo H; Luan X; He M; Li F; Burnett J; Truchan N; Sun D
Mol Pharm; 2020 Jul; 17(7):2275-2286. PubMed ID: 32485107
[TBL] [Abstract][Full Text] [Related]
14. Effect of size and pegylation of liposomes and peptide-based synthetic lipoproteins on tumor targeting.
Tang J; Kuai R; Yuan W; Drake L; Moon JJ; Schwendeman A
Nanomedicine; 2017 Aug; 13(6):1869-1878. PubMed ID: 28434931
[TBL] [Abstract][Full Text] [Related]
15. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models.
Badr G; Al-Sadoon MK; Rabah DM
Free Radic Biol Med; 2013 Dec; 65():175-189. PubMed ID: 23811005
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.
Ye J; Xia X; Dong W; Hao H; Meng L; Yang Y; Wang R; Lyu Y; Liu Y
Int J Nanomedicine; 2016; 11():4125-40. PubMed ID: 27601899
[TBL] [Abstract][Full Text] [Related]
18. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
19. Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133.
Yin H; Xiong G; Guo S; Xu C; Xu R; Guo P; Shu D
Mol Ther; 2019 Jul; 27(7):1252-1261. PubMed ID: 31085078
[TBL] [Abstract][Full Text] [Related]
20. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
